Search This Blog

Thursday, February 6, 2020

Seattle Genetics EPS beats by $0.59, beats on revenue

Seattle Genetics (NASDAQ:SGEN): Q4 GAAP EPS of $0.14 beats by $0.59.
Revenue of $289.8M (+66.1% Y/Y) beats by $70.59M.
Shares +2.6%.
Press Release
https://seekingalpha.com/news/3539403-seattle-genetics-eps-beats-0_59-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)